Novavax vaccine over 90% effective in U.S. trial

4 monate vor

Novavax reported late-stage data from its U.S.-based clinical trial showing its vaccine is more than 90% effective against COVID-19 across a variety of variants of the virus #News #Reuters #Vaccine #Novavax #VaccineTrial #Covid #Coronavirus Subscribe: Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled. Get the latest news on: Follow Reuters on Facebook: Follow Reuters on Twitter: Follow Reuters on Instagram:
Aus der Quelle lesen